Trademark Information

Application ID
Status
Date of Application
21 December 2022
Classes
5
Proprietor
802, Advent Atria, Opp. Kingston Complex, Chincholi Bunder Road, Malad(w), Mumbai 400 064
Attorney
G.S. Rijhwani & Co.[5893]
Office Nos. 501 & 502 Makani Centre, Plot No. 522, 35 Th Road, Tps Iii, Near Tsec College, Bandra West, Mumbai 400 050, Maharashtra
Type
Word
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
Valid / Upto
Description
[Class : 5] Pharmaceuticals, Medical And Veterinary Preparations; Sanitary Preparations For Medical Purposes; Dietetic Food And Substances Adapted For Medical Or Veterinary Use, Food For Babies; Dietary Supplements For Human Beings And Animals; Plasters, Materials For Dressings; Material For Stopping Teeth, Dental Wax; Disinfectants; Preparations For Destroying Vermin;Fungicides, Herbicides

Documents

Examination Report

Uploaded Documents

1 TM-A(TRADE MARKS APPLICATION) 21 Dec 2022
2 Reply to Exam Report (MIS-R) 03 Jul 2023
3 Authorization Letter 10 Apr 2024
4 Letter of Withdrawal 01 Aug 2024
5 Authorization Letter 01 Aug 2024

Correspondence and Notices

1 EXAMINATION REPORT 15534680   03 Jul 2023
2 Hearing Notice (Show Cause) 17637696   06 Mar 2024
3 Hearing Notice (Show Cause) 18349588   20 Jun 2024
4 Tribunal Withdrawn Notice for : 5731953 18624416 6847016 02 Aug 2024

Frequently Asked Questions

When was the trademark applied?

The application for Moxaff was made on 21 December 2022.

Who is the applicant for Moxaff?

The trademark applicant for Moxaff is ARCHERCHEM HEALTHCARE.

In what class is the trademark applied to?

Moxaff is applied in class(es) 5.

What is the status of the trademark application?

Application for Moxaff is on Withdrawn stage.

What is the application ID of the trademark?

Application Id allotted to Moxaff is 5731953.

Who is the trademark agent or attorney?

Trademark agent or attorney for the application is G.S. Rijhwani & Co.

What is the type of trademark application?

Moxaff filed with the Intellectual property office as a WORD.